PS-341 in Treating Women With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: PS-341 may stop the growth of tumor cells by blocking the enzymes necessary for
cancer cell growth.
PURPOSE: Phase II trial to study the effectiveness of PS-341 in treating women who have
metastatic breast cancer.